Workflow
DRINDA(02865)
icon
Search documents
钧达股份(02865) - 海南钧达新能源科技股份有限公司关於董事会完成换届选举暨聘任高阶主管的公告
2025-07-31 14:07
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不 負 責,對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明,並 明 確 表 示,概 不 對 因 本 公 告 全部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責 任。 Hainan Drinda New Energy Technology Co., Ltd. 海南鈞達新能源科技股份有限公司 (於中華人民共和國註冊成立的股份有限公司) (股份代號:02865) 海外監管公告 本公告乃根據香港聯合交易所有限公司證券上市規則第13.10B條 而 作 出。 茲載列海南鈞達新能源科技股份有限公司在深圳證券交易所網站刊登了以下 公 告。茲 載 列 如 下,僅 供 參 閱。 特 此 公 告。 承董事會命 海南鈞達新能源科技股份有限公司 董事長兼執行董事 陸徐楊先生 海南钧达新能源科技股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 中 國 • 海 口 2025年7月31日 截 至 本 公 告 日 期,董 事 會 成 員 為 執 行 董 事 陸 徐 楊 先 生、張 滿 ...
钧达股份(02865) - 海南钧达新能源科技股份有限公司2025年第三次临时股东会决议公告
2025-07-31 14:05
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不 負 責,對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明,並 明 確 表 示,概 不 對 因 本 公 告 全部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責 任。 Hainan Drinda New Energy Technology Co., Ltd. 海南鈞達新能源科技股份有限公司 (於中華人民共和國註冊成立的股份有限公司) (股份代號:02865) 海外監管公告 本公告乃根據香港聯合交易所有限公司證券上市規則第13.10B條 而 作 出。 茲載列海南鈞達新能源科技股份有限公司在深圳證券交易所網站刊登了以下 公 告。茲 載 列 如 下,僅 供 參 閱。 特 此 公 告。 承董事會命 海南鈞達新能源科技股份有限公司 董事長兼執行董事 陸徐楊先生 中 國 • 海 口 2025年7月31日 截 至 本 公 告 日 期,董 事 會 成 員 為 執 行 董 事 陸 徐 楊 先 生、張 滿 良 先 生 及 鄭 洪 偉 先 生;非 執 行 董 事 徐 曉 平 先 生 及 徐 勇 先 生;職 工 代 表 董 事 鄭 虹 ...
钧达股份: H股公告-2025年第三次临时股东会通函、通告及委任表格
Zheng Quan Zhi Xing· 2025-07-15 16:28
Core Points - Hainan Drinda New Energy Technology Co., Ltd. is proposing amendments to its articles of association and related rules, including the abolition of the supervisory board [1][3][4] - The company plans to revise its internal governance system and elect/re-elect directors at the upcoming extraordinary general meeting [1][3][4] - The company intends to appoint and reappoint auditors for the fiscal year 2025, specifically Zhonghui CPA as the domestic auditor and Deloitte as the overseas auditor [1][3][9] - The proposed adjustment of independent non-executive directors' remuneration to RMB 120,000 per year (including tax) is also on the agenda [1][7][9] Summary by Sections Proposed Amendments - The company aims to amend its articles of association to abolish the supervisory board, transferring its powers to the audit committee [3][4] - The amendments are intended to enhance corporate governance and comply with legal and regulatory requirements [3][4] Internal Governance Revisions - The company will revise its board meeting rules and shareholders' meeting rules to align with the changes in governance structure [4][5] - Additional internal governance systems, including related party transaction decision-making and external guarantee systems, will also be revised [4][5] Director Elections - The fifth board of directors will consist of 10 members, including three executive directors, two non-executive directors, one employee representative director, and four independent non-executive directors [5][6] - The nomination committee has ensured that independent non-executive director candidates meet the independence requirements set by the Hong Kong Listing Rules [6] Auditor Appointments - The board has resolved to reappoint Zhonghui CPA as the domestic auditor and appoint Deloitte as the overseas auditor for the fiscal year 2025 [9] - The remuneration for the auditors will be determined based on the audit workload and scope [9] Shareholder Meeting Details - The extraordinary general meeting is scheduled for July 31, 2025, at 2:30 PM in Suzhou, Jiangsu Province [1][10] - Shareholders must submit their attendance and proxy forms by July 24, 2025, to participate in the meeting [10][11]
钧达股份: H股公告-认购理财产品
Zheng Quan Zhi Xing· 2025-07-11 00:16
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責,對其準確性 或完整性亦不發表任何聲明,並明確表示概不就因本公告全部或任何部分內容所產生或因依賴 該等內容而引致的任何損失承擔任何責任。 Hainan Drinda New Energy Technology Co., Ltd. 海南鈞達新能源科技股份有限公司 (於中華人民共和國註冊成立的股份有限公司) (股份代號:02865) 有關認購理財產品的須予披露交易 認購理財產品 董事會宣佈,於2025年1月24日、2025年2月28日、2025年3月11日、2025年 司滁州捷泰利用其閒置資金認購若干該等理財產品,包括認購第一項興業銀行 理財產品、第十四項興業銀行理財產品、第十五項興業銀行理財產品、第二項 興業銀行理財產品、第三項興業銀行理財產品、第四項興業銀行理財產品及第 十一項興業銀行理財產品,認購金額分別為人民幣30百萬元、人民幣100百萬 元、人民幣100百萬元、人民幣50百萬元、人民幣100百萬元、人民幣100百萬 元及人民幣100百萬元。 董事會宣佈,於2025年4月30日、2025年5月7日、2025年6月5日及2025年7月3 ...
格隆汇个股放量排行榜 | 7月5日
Ge Long Hui· 2025-07-05 09:43
Core Insights - The data indicates significant trading volume increases for various companies, suggesting heightened investor interest and potential market movements [1][2][3][4][5] Group 1: Companies with Notable Volume Increases - 阳光能源 (00757) reported a volume ratio of 2.35, indicating strong trading activity [2] - 长城汽车 (02333) had a volume ratio of 2.21, reflecting increased investor engagement [2] - 郑煤机 (00564) showed a volume ratio of 1.92, suggesting a notable rise in trading [2] Group 2: Additional Companies with Increased Trading Activity - 万国数据-SW (09698) recorded a volume ratio of 1.83, indicating significant market interest [2] - 映恩生物-B (09606) had a volume ratio of 1.78, reflecting heightened trading activity [2] - 超盈国际控股 (02111) reported a volume ratio of 1.71, suggesting increased investor focus [2] Group 3: Companies with Moderate Volume Ratios - 中国能源建设 (03996) had a volume ratio of 1.70, indicating a solid level of trading activity [2] - 亚信科技 (01675) reported a volume ratio of 1.60, reflecting moderate investor interest [2] - 金宝通 (00320) showed a volume ratio of 1.53, suggesting a rise in trading volume [2] Group 4: Companies with Lower Volume Ratios - 中国水务 (00855) had a volume ratio of 1.52, indicating stable trading activity [2] - 广汽集团 (02238) reported a volume ratio of 1.52, reflecting consistent investor engagement [2] - 凯莱英 (06821) showed a volume ratio of 1.52, suggesting steady trading interest [2]
智通AH统计|6月10日
智通财经网· 2025-06-10 08:22
Core Insights - The article highlights the top and bottom AH share premium rates as of June 10, with Northeast Electric (00042) leading at a premium rate of 958.82% and Ningde Times (03750) at the bottom with -1.75% [1][2]. Group 1: Top AH Share Premium Rates - Northeast Electric (00042) has a premium rate of 958.82% with H-share priced at 0.255 HKD and A-share at 2.25 CNY [2]. - Hongye Futures (03678) follows with a premium rate of 271.39%, H-share at 3.390 HKD and A-share at 10.51 CNY [2]. - Andeli Juice (02218) ranks third with a premium rate of 268.02%, H-share at 15.980 HKD and A-share at 49.1 CNY [2]. Group 2: Bottom AH Share Premium Rates - Ningde Times (03750) has a premium rate of -1.75%, with H-share at 299.600 HKD and A-share at 245.75 CNY [2]. - WuXi AppTec (02359) has a premium rate of 5.05%, H-share at 74.000 HKD and A-share at 64.9 CNY [2]. - China Merchants Bank (03968) has a premium rate of 5.13%, H-share at 50.900 HKD and A-share at 44.67 CNY [2]. Group 3: Top Share Deviation Values - BYD Company (01211) leads with a deviation value of 202.33%, H-share at 135.600 HKD and A-share at 353.13 CNY [2]. - Longpan Technology (02465) follows with a deviation value of 30.49%, H-share at 6.910 HKD and A-share at 15.33 CNY [2]. - Yanzhou Coal Mining (01171) has a deviation value of 11.04%, H-share at 8.250 HKD and A-share at 12.79 CNY [2]. Group 4: Bottom Share Deviation Values - China Shipbuilding Defense (00317) has the lowest deviation value at -46.55%, H-share at 13.360 HKD and A-share at 24.9 CNY [3]. - Zhejiang Shibao (01057) follows with -37.20%, H-share at 4.650 HKD and A-share at 11.93 CNY [3]. - Junshi Biosciences (01877) has a deviation value of -35.39%, H-share at 24.600 HKD and A-share at 37 CNY [3].
异动盘点0603|光大控股此前投资稳定币巨头,狂飙21%;汽车股回暖、医药股走强;BioNTech获91亿天价并购
贝塔投资智库· 2025-06-03 04:00
Group 1: Stock Movements and Market Reactions - JunDa Co., Ltd. (02865) fell by 12.69% due to weak fundamentals, expected shareholder sell-off, and cash flow concerns [1] - Rongchang Biopharmaceutical (09995) rose by 4.61% after ASCO announced positive data for RC108 combined with vorinostat, enhancing its commercialization prospects [1] - Datang Gold (08299) increased by 7.27% as it partnered with Wuxi to develop AI mining applications, benefiting from gold's safe-haven demand [1] - Kanglong Chemical (03759) gained 4.35% by investing in a biopharmaceutical fund, strengthening its investment ecosystem [1] - Automotive stocks surged following a significant increase in May's new energy vehicle sales, with Li Auto (2015) rising nearly 6% and Great Wall Motors (2333) up over 3% [1] - Gold stocks led the market as COMEX gold prices returned to $3,400, with Goldman Sachs predicting $4,200, driven by geopolitical tensions [1] Group 2: Company-Specific Developments - Changfei Optical Fiber (06869) rose by 8.34% as its Wuhan base began mass production of 6-inch silicon carbide wafers, achieving a 97% yield rate [2] - China Shipbuilding Defense (00317) increased by 7.58% after securing the highest global new orders from January to April, with Q1 net profit up 1,099% [2] - Hengrui Medicine (00013) rose by 5.09% as SACHI III phase data met expectations, opening up market space for MET amplification lung cancer treatment [2] - Lepu Medical Technology (02157) gained 5.76% following positive ASCO data for its ADC drug MRG003, boosting approval expectations for nasopharyngeal carcinoma [2] - Aidi Kang Holdings (09860) increased by 5.2% after acquiring Suzhou Yuande Youqin to enhance blood disease diagnostics [2] - NetDragon (00777) rose by 5.82% due to its collaboration with Thailand on an AI education platform, attracting investor interest [2] Group 3: Notable Market Trends - China Everbright Holdings (00165) surged over 21% following the enactment of Hong Kong's stablecoin regulations, with Circle's IPO expectations boosting related equity valuations [3] - iFlytek Medical (02506) rose by 6.62% as its medical AI model demonstrated superior accuracy, supported by favorable policies [3] - MicroPort NeuroTech (02172) increased by 9.59% as it initiated clinical research on brain-machine interfaces, benefiting from policy incentives [3] - Longpan Technology (02465) rose by 14.9% after its subsidiary signed a $7.1 billion contract with Yiwei Lithium Energy for lithium iron phosphate [4] - Hansoh Pharmaceutical (03692) gained 3.85% after reaching a global licensing agreement with Regeneron, receiving an $80 million upfront payment [4] Group 4: U.S. Market Highlights - Steel and aluminum stocks surged over 10%-28% as Trump proposed increasing steel tariffs to 50%, benefiting domestic companies [5] - Blueprint Medicines (BPMC.US) rose by 26% following Sanofi's $9.1 billion acquisition, enhancing its rare disease pipeline [5] - BioNTech (BNTX.US) increased by 18% due to a collaboration with Bristol-Myers Squibb, securing a $1.5 billion upfront payment [5] - Applied Digital (APLD.US) surged by 48.46% after signing a $7 billion AI data center lease, validating its business model [5] - Tempus AI (TEM.US) rose by 15% as it launched an AI medical innovation plan, attracting investor interest [7]
海南钧达新能源科技股份有限公司关于稳定价格期结束及超额配售权失效的公告
Core Viewpoint - The announcement details the end of the stabilization period and the expiration of the over-allotment option for H shares of Hainan Junda New Energy Technology Co., Ltd. [1][2] Group 1: Stabilization Period - The stabilization period for the global offering of 63,432,300 H shares ended on June 1, 2025, which is 30 days after the deadline for submitting applications for the Hong Kong public offering [1]. - During the stabilization period, no stabilization actions were taken by the stabilizing agent, Huatai Financial Holdings (Hong Kong) Limited, or any of its affiliates [1]. Group 2: Over-allotment Option - The overall coordinator, representing international underwriters, did not exercise the over-allotment option during the stabilization period, resulting in its expiration on June 1, 2025 [2]. - There were no changes in the company's shares before and after the expiration of the over-allotment option [2]. Group 3: Public Holding Requirement - Following the end of the stabilization period, the company continues to meet the minimum public holding requirements imposed by the Hong Kong Stock Exchange Listing Rules [2].
一周港股IPO:中企云链、英矽智能等8家递表,宁德时代等3家通过聆讯
Cai Jing Wang· 2025-05-12 10:08
Summary of Key Points Core Viewpoint The Hong Kong IPO market has seen significant activity from May 5 to May 11, with 8 companies submitting applications, 3 companies passing hearings, 1 company going public, and 3 companies listing. Group 1: IPO Applications - A total of 8 companies submitted IPO applications, including Zhongqi Yunlian, MIRXES, YS Intelligent, Xidi Zhijia, Tong Shifu, Zhejing Electronics, Zhongding Integration, and Fuyou Payment [2][3] - Zhongqi Yunlian, established in 2015, is a leading independent digital financial platform in China, with a projected revenue of 6.52 billion RMB in 2022, increasing to 9.91 billion RMB by 2024 [3] - MIRXES, founded in 2014, specializes in miRNA technology for disease screening, with projected revenues of approximately 177.59 million USD in 2022, growing to 202.83 million USD by 2024 [4][5] - YS Intelligent, focusing on AI-driven pharmaceutical solutions, has raised over 500 million USD from notable investors and has a post-money valuation of 1.33 billion USD [6] - Xidi Zhijia, a provider of autonomous driving solutions, reported revenues of 310.56 million RMB in 2022, expected to reach 410 million RMB by 2024 [7] - Tong Shifu, established in 2013, leads the copper cultural products market in China with a 35% market share, projecting revenues of 503 million RMB in 2022 [8] - Zhejing Electronics, a pioneer in smart cockpit solutions, reported revenues of approximately 214 million RMB in 2022, with expectations of growth [9] - Zhongding Integration, a provider of smart logistics solutions, reported revenues of approximately 1.643 billion RMB in 2022, with a projected increase [11] - Fuyou Payment, a digital payment technology platform, reported revenues of approximately 1.142 billion RMB in 2022, with growth anticipated [12] Group 2: Companies Passing Hearings - Heng Rui Pharmaceutical, a leading innovative pharmaceutical company, reported revenues of 21.275 billion RMB in 2022, expected to grow to 27.985 billion RMB by 2024 [13][14] - Ningde Times, a leader in battery manufacturing, is expected to raise between 4 billion to 5 billion USD in its IPO, with a market share of 37.9% in the global battery market by 2024 [15][16] - Jihong Co., a dual-driven company in cross-border e-commerce and paper packaging, reported revenues of 5.376 billion RMB in 2022, with growth expected [17] Group 3: IPO and Listings - Green Tea Group is set to launch its IPO, offering 168 million shares at a price of 7.19 HKD per share, with significant interest from cornerstone investors [18] - Boleton, listed on May 7, priced at 18 HKD per share, saw a closing price of 24.9 HKD, reflecting a 38% increase [19] - Hu Shang Ayi, listed on May 8, had an opening price of 190.6 HKD, closing at 158.4 HKD, a 40.03% increase from its issue price [20] - Jun Da Co., also listed on May 8, opened at 22.2 HKD and closed at 26.6 HKD, marking a 20.09% increase [20] Group 4: Market Developments - The Hong Kong Stock Exchange has launched a "Tech Company Fast Track" to facilitate IPO applications for technology and biotech companies, allowing for confidential submissions [21]
光伏首家“A+H”股!该企业成功在香港主板上市
Sou Hu Cai Jing· 2025-05-09 06:34
Core Insights - The third XBC Battery and Component Technology Forum 2025 will be held on May 15-16 in Jiaxing, focusing on advancements in photovoltaic technology and market trends [6][13]. Company Developments - JunDa Co., Ltd. officially listed on the Hong Kong Stock Exchange on May 8, becoming the first photovoltaic company to operate under an "A+H" dual capital platform [2][4]. - The company issued 63.43 million shares at a price of HKD 22.15 per share, with proceeds aimed at establishing overseas photovoltaic cell production bases and enhancing technology research and development [4]. - JunDa's N-type battery technology has achieved a conversion efficiency of over 26.3%, with a 30% reduction in non-silicon costs, establishing a competitive edge in the market [4][5]. Industry Trends - The global demand for photovoltaic products is increasing, with JunDa's overseas sales rising from 23.85% in 2024 to 58.00% in Q1 2025, indicating strong market penetration [5]. - The XBC battery technology is gaining traction, with significant advancements in efficiency and production capacity expected in 2025, driven by leading companies in the industry [12][14]. - The market share of XBC batteries is projected to increase significantly, with estimates suggesting a market share of approximately 5% in 2024 compared to 2023 [12]. Forum Agenda Highlights - The forum will cover topics such as the competitive landscape of XBC, TOPCon, and heterojunction batteries, as well as the advantages of XBC components in distributed applications [13][14]. - Key discussions will include advancements in TBC, HBC, and HTBC technologies, cost reduction strategies, and the application of advanced conductive pastes and metallization techniques in XBC batteries [14][15].